Luigi Celio

3.2k total citations
82 papers, 2.2k citations indexed

About

Luigi Celio is a scholar working on Oncology, Surgery and Physiology. According to data from OpenAlex, Luigi Celio has authored 82 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 38 papers in Surgery and 17 papers in Physiology. Recurrent topics in Luigi Celio's work include Nausea and vomiting management (31 papers), Anesthesia and Pain Management (25 papers) and Estrogen and related hormone effects (17 papers). Luigi Celio is often cited by papers focused on Nausea and vomiting management (31 papers), Anesthesia and Pain Management (25 papers) and Estrogen and related hormone effects (17 papers). Luigi Celio collaborates with scholars based in Italy, Switzerland and United States. Luigi Celio's co-authors include Emilio Bajetta, Nicoletta Zilembo, Roberto Buzzoni, Antonia Martinetti, Maria Di Bartolomeo, Giuseppe Procopio, Luigi Mariani, Ettore Seregni, Emilio Bombardieri and Leonardo Ferrari and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Luigi Celio

81 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luigi Celio Italy	22	1.2k	547	465	408	383	82	2.2k
Antonia Martinetti Italy	32	1.5k 1.2×	278 0.5×	460 1.0×	837 2.1×	501 1.3×	121	2.8k
Christina L. Roland United States	30	1.7k 1.4×	612 1.1×	215 0.5×	303 0.7×	585 1.5×	126	3.6k
Tetsuro Ishikawa Japan	25	763 0.6×	514 0.9×	148 0.3×	283 0.7×	352 0.9×	136	2.0k
Abir Al Ghuzlan France	33	561 0.5×	1.7k 3.2×	240 0.5×	252 0.6×	971 2.5×	96	3.6k
Francesca Ragusa Italy	26	489 0.4×	194 0.4×	337 0.7×	205 0.5×	175 0.5×	71	2.4k
Bo Youn Cho South Korea	37	518 0.4×	1.0k 1.8×	517 1.1×	312 0.8×	148 0.4×	123	3.5k
David Yü Greenblatt United States	27	1.1k 0.9×	1.0k 1.9×	103 0.2×	196 0.5×	204 0.5×	51	2.6k
Claes Juhlin Sweden	24	734 0.6×	588 1.1×	140 0.3×	664 1.6×	331 0.9×	48	2.0k
John E. Phay United States	24	321 0.3×	1.3k 2.4×	248 0.5×	231 0.6×	260 0.7×	71	2.6k
Ilaria Ruffilli Italy	27	528 0.4×	188 0.3×	336 0.7×	248 0.6×	150 0.4×	54	2.2k

Countries citing papers authored by Luigi Celio

Since Specialization

Citations

This map shows the geographic impact of Luigi Celio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Celio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Celio more than expected).

Fields of papers citing papers by Luigi Celio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Celio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Celio. The network helps show where Luigi Celio may publish in the future.

Co-authorship network of co-authors of Luigi Celio

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Celio. A scholar is included among the top collaborators of Luigi Celio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Celio. Luigi Celio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caputo, Roberta, Marina Elena Cazzaniga, Andrea Sbrana, et al.. (2020). Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study. BMC Cancer. 20(1). 232–232. 7 indexed citations

Vernieri, Claudio, Monica Milano, Marta Brambilla, et al.. (2019). Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives. Critical Reviews in Oncology/Hematology. 139. 53–66. 158 indexed citations

Aapro, Matti, Florian Scotté, Yolanda Escobar, et al.. (2018). Evaluation of practice patterns for prevention of chemotherapy (CT)-induced nausea and vomiting (CINV) and antiemetic guidelines (GLs) adherence based on real-world prescribing data. Annals of Oncology. 29. viii603–viii603. 9 indexed citations

Restelli, Umberto, G. Saibene, Patrizia Nardulli, et al.. (2017). Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy. BMJ Open. 7(7). e015645–e015645. 15 indexed citations

Herrstedt, Jørn, Fausto Roila, David Warr, et al.. (2016). 2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy. Supportive Care in Cancer. 25(1). 277–288. 98 indexed citations

Celio, Luigi, et al.. (2015). Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy. PubMed. 10. 75–75. 21 indexed citations

Celio, Luigi, Erminio Bonizzoni, Emilio Bajetta, et al.. (2012). Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials. Supportive Care in Cancer. 21(2). 565–573. 24 indexed citations

Celio, Luigi, S. Frustaci, Angela Buonadonna, et al.. (2010). Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial. Supportive Care in Cancer. 19(8). 1217–1225. 76 indexed citations

Celio, Luigi, Cora N. Sternberg, Roberto Labianca, et al.. (2009). Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study. Annals of Oncology. 20(6). 1062–1067. 16 indexed citations

10.

Bajetta, Emilio, Luigi Celio, Marco Platania, et al.. (2009). Single-Institution Series of Early-Stage Merkel Cell Carcinoma: Long-Term Outcomes in 95 Patients Managed with Surgery Alone. Annals of Surgical Oncology. 16(11). 2985–2993. 47 indexed citations

11.

Cappelletti, Vera, Manuela Gariboldi, Loris De Cecco, et al.. (2008). Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer. Endocrine Related Cancer. 15(2). 439–449. 11 indexed citations

12.

Bajetta, Emilio, et al.. (2007). Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer. Annals of Oncology. 18(11). 1810–1816. 30 indexed citations

13.

Bajetta, E., Luigi Celio, Roberto Buzzoni, et al.. (2003). Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer. Annals of Oncology. 14(10). 1543–1548. 49 indexed citations

14.

Bajetta, Emilio, L. Ferrari, Giuseppe Procopio, et al.. (2002). Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Annals of Oncology. 13(4). 614–621. 88 indexed citations

15.

Martinetti, Antonia, Leonardo Ferrari, Luigi Celio, et al.. (2000). The luteinising hormone–releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers. The Journal of Steroid Biochemistry and Molecular Biology. 75(1). 65–73. 3 indexed citations

16.

Bajetta, Emilio, Leonardo Ferrari, Antonia Martinetti, et al.. (1999). Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer. 86(5). 858–865. 220 indexed citations

17.

Bajetta, Emilio, Angelo Di Leo, Laura Biganzoli, et al.. (1996). Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease.. Journal of Clinical Oncology. 14(9). 2546–2551. 114 indexed citations

18.

Bajetta, Emilio, Nicoletta Zilembo, Roberto Buzzoni, et al.. (1994). Goserelin in Premenopausal Advanced Breast Cancer: Clinical and Endocrine Evaluation of Responsive Patients. Oncology. 51(3). 262–269. 13 indexed citations

19.

Bajetta, Emilio, Nicoletta Zilembo, Maria Di Bartolomeo, et al.. (1993). Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a: A study by the Italian trials in Medical Oncology Group. Cancer. 72(10). 3099–3105. 107 indexed citations

20.

Correale, Pierpaolo, Antonio Domenico Procopio, Luigi Celio, et al.. (1992). Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer-and lymphokine-activated-killer-mediated cytotoxicity. Cancer Immunology Immunotherapy. 34(4). 272–278. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact